European patient shows signs of PML

The pharmaceutical sponsor of Tecfidera (BG-12), Biogen Idec, has this week reported one case of Progressive Multifocal Leukoencephalopathy

Newsletter subscription

  • This field is for validation purposes and should be left unchanged.

Pro bono support for MS Research Australia